Angelini Ventures
Headquarter
Cambridge, MA - United States
Milestones
Founded: 2020
Invested: 2022
Founders / CEO
Steven Tregay, CEO
Vertical
Biotech
Board Participation
Thomas Thestrup, Board Member
Operator of a biopharmaceutical incubator intended to accelerate the development of novel therapeutics for neurodegenerative diseases. The company's platform offers expertise, access to R&D resources and operational support to early-stage companies focused on the development of novel therapeutics for neurodegenerative diseases, enabling customers to develop and advance their drug development programs, with the goal of bringing new treatments to patients in an efficient manner.